WASHINGTON—The White House considered issuing an executive order greatly expanding the use of investigational drugs against the new coronavirus, but was met with objections from Food and Drug Administration scientists who warned it could pose unneeded risks to patients, according to a senior government official.

President Trump tweeted that he is planning a briefing Wednesday that will pertain to the FDA. It couldn’t immediately be determined if that briefing would deal with expanded use of testing drugs against the virus.

Read More